ACHV Achieve Life Sciences, Inc. - Common Shares
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$7,24
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,62rendah 52m
$8,64tinggi 52m
Kapitalisasi Pasar (MRQ)
$744M
P/E
-4.0
EPS
$-1.25
lencana Anda
Rentang 52M
$3–$9
Peringkat Analis
BUY
Target Harga
$14
P/E
-4.0
ROE
·
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ACHV Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$7.24
Kapitalisasi Pasar (MRQ)
$744M
P/E
-4.0
EPS
$-1.25
Rentang 52M
$3–$9
ACHV Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 31 Juli 2020 | 1-for-20 | Terbalik |
| 24 Mei 2018 | 1-for-10 | Terbalik |
| 3 Agu 2017 | 1-for-11 | Terbalik |
| 21 Agu 2008 | 1-for-18 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan·2018-12-31 → 2019-12-31
EPS$-1.252020-12-31 → 2025-12-31
Arus Kas Bebas·2016-12-31 → 2023-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ACHV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -4.0rata-rata 5T ≈-2.4 | ≈-2.4 | · | · | |
| P/B (MRQ) | -50.7rata-rata 5T ≈-17.3 | ≈-17.3 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | -48.6rata-rata 5T ≈7.6 | ≈7.6 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ACHV | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 1.0rata-rata 5T ≈5.4 | ≈5.4 | 8.0 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-54.8%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 6, 2026 | $-0.80 | $-0.16 | -405.7% |
| 31 Maret 2026 | Mei 11, 2026 | $-0.19 | $-0.31 | 39.6% |
| 31 Des. 2025 | $-0.28 | $-0.28 | -1.1% | |
| 30 Sep. 2025 | $-0.28 | $-0.26 | -6.7% | |
| 30 Juni 2025 | $-0.37 | $-0.37 | 0.35% | |
| 31 Maret 2025 | $-0.37 | $-0.37 | 0.16% | |
| 31 Des. 2024 | $-0.36 | $-0.33 | -10.3% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | · | $23M | $16M | $30M | $24M | $7M | $10M | $6M | |
| SG&A Expense | · | $16M | $11M | $11M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $55M | $39M | $27M | $41M | $33M | $15M | $17M | $13M | |
| Interest Expense | · | · | $3M | $2M | · | · | · | · | |
| Interest Income | $1M | $2M | $825.0K | $199.0K | $17.0K | $69.0K | $170.0K | $171.0K | |
| Other Non-op | $-36.0K | $-30.0K | $-9.0K | $40.0K | $-75.0K | $-49.0K | $-37.0K | $-45.0K | |
| Pretax Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Net Income | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| EPS (Basic) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| EPS (Diluted) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · | |
| Shares (Basic) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · | |
| Shares (Diluted) | 43,594,652 | 32,071,146 | 19,827,534 | 10,593,034 | 8,119,836 | 2,718,909 | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $13M | $16M | $25M | $43M | $36M | $17M | $10M | |
| Short-term Investments | $15M | $22M | · | · | · | · | · | $5M | |
| Receivables | · | · | · | · | · | · | $8.0K | $7.0K | |
| Prepaid Expense | · | $2M | $1M | $2M | $1M | $1M | $670.0K | $926.0K | |
| Current Assets | $40M | $36M | $17M | $27M | $45M | $37M | $17M | $16M | |
| PP&E (Net) | $3.0K | $8.0K | $13.0K | $4.0K | $15.0K | $42.0K | $57.0K | $35.0K | |
| PP&E (Gross) | $256.0K | $256.0K | $256.0K | $303.0K | $302.0K | $674.0K | $657.0K | $755.0K | |
| Accum. Depreciation | $253.0K | $248.0K | $243.0K | $299.0K | $287.0K | $632.0K | $600.0K | $720.0K | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $751.0K | $974.0K | $1M | $1M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | $187.0K | $187.0K | $118.0K | |
| Total Assets | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Accounts Payable | · | $2M | $618.0K | $2M | $841.0K | $332.0K | $859.0K | $144.0K | |
| Current Liabilities | $9M | $7M | $21M | $22M | $5M | $3M | $3M | $3M | |
| Capital Leases | $5.0K | $66.0K | $6.0K | $69.0K | $4.0K | $77.0K | $159.0K | $12.0K | |
| Total Liabilities | $20M | $18M | $21M | $22M | $19M | $3M | $3M | $3M | |
| Common Stock | $121.0K | $103.0K | $90.0K | $87.0K | $79.0K | $76.0K | $41.0K | $18.0K | |
| Retained Earnings | $-260M | $-206M | $-166M | $-136M | $-94M | $-60M | $-46M | $-25M | |
| AOCI | $10.0K | $31.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $22M | $21M | $-1M | $8M | $28M | $37M | $18M | $16M | |
| Liabilities + Equity | $42M | $39M | $19M | $30M | $48M | $40M | $21M | $19M | |
| Shares Outstanding | 53,233,988 | 34,685,072 | 21,165,760 | 17,897,029 | 9,453,542 | 6,111,735 | 1,474,258 | 6,721,117 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $228.0K | $229.0K | $228.0K | $236.0K | $250.0K | $255.0K | · | · | |
| Stock-based Comp | $9M | $5M | $3M | $3M | $2M | $1M | $1M | $854.0K | |
| Amort. of Intangibles | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |
| Operating Cash Flow | $-49M | $-30M | $-24M | $-38M | $-29M | $-13M | $-15M | $-11M | |
| CapEx | $3.0K | · | $21.0K | · | · | $17.0K | $53.0K | $46.0K | |
| Investing Cash Flow | $6M | $-22M | $-21.0K | · | · | $-17.0K | $5M | $-5M | |
| Financing Cash Flow | $52M | $49M | $15M | $19M | $37M | $33M | $17M | $20M | |
| Net Change in Cash | $8M | $-3M | $-9M | $-18M | $7M | $19M | $7M | $4M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | $-24M | · | · | $-13M | $-15M | $-11M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -137.3% | -120.8% | · | -75.5% | -48.0% | -81.6% | -87.6% | |
| ROE | · | -152.4% | -2302.3% | · | -105.7% | -46.8% | -125.2% | -84.7% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 5.5 | 0.8 | · | 9.8 | 12.6 | 6.0 | 4.8 | |
| Quick Ratio | · | 5.1 | 0.7 | · | 9.5 | 12.2 | 5.8 | 4.5 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.60 | $-0.07 | · | $2.97 | $6.10 | $0.61 | $2.35 | |
| Cash Flow / Share | · | $-0.93 | $-1.23 | · | · | · | · | · | |
| Cash / Share | · | $0.37 | $0.73 | · | $4.55 | $5.87 | $0.57 | $1.42 | |
| EPS (TTM) | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | $0 | $0 | |
| Net Income TTM | $-55M | $-40M | $-30M | $-42M | $-33M | $-15M | $-16M | $-13M | |
| Market Cap | · | $122M | $87M | · | $74M | $50M | $313M | $163M | |
| P/E | -4.0 | -2.8 | -2.7 | -0.6 | -1.9 | -1.5 | · | · | |
| P/B | · | 5.8 | -60.2 | · | 2.6 | 1.3 | 17.3 | 10.3 | |
| P / Tangible Book | 13.4 | 6.5 | · | 7.5 | 2.9 | 1.4 | · | · | |
| P / Cash Flow | · | -4.1 | -3.6 | · | -2.5 | -3.7 | -20.5 | -15.3 | |
| P / FCF | · | · | -3.6 | · | · | -3.7 | -20.5 | -15.2 | |
| Earnings Yield | -25.1% | -35.2% | -36.4% | -163.3% | -52.4% | -66.9% | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $5M | $7M | $7M | · | $8M | $5M | $3M | $4M | $5M | $6M | $10M | $7M | $4M | |
| SG&A Expense | · | · | · | $9M | $6M | $6M | · | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $18M | $10M | $15M | $15M | $13M | $13M | $12M | $12M | $8M | $6M | $7M | $8M | $9M | $13M | $10M | $7M | |
| Interest Expense | · | · | · | · | · | · | · | $366.0K | $804.0K | $813.0K | $781.0K | $712.0K | $573.0K | $481.0K | $404.0K | $357.0K | |
| Interest Income | $1M | $297.0K | $427.0K | $554.0K | $192.0K | $322.0K | $482.0K | $673.0K | $833.0K | $368.0K | $262.0K | $193.0K | $162.0K | $73.0K | $4.0K | $4.0K | |
| Other Non-op | $-5.0K | $-13.0K | $7.0K | $-5.0K | $-59.0K | $21.0K | $-5.0K | $-8.0K | $-2.0K | $-15.0K | $-17.0K | $-6.0K | $-3.0K | $-30.0K | $5.0K | $6.0K | |
| Net Income | $-75M | $-10M | $-15M | $-14M | $-13M | $-13M | $-12M | $-13M | $-8M | $-6M | $-7M | $-8M | $-9M | $-13M | $-10M | $-8M | |
| EPS (Basic) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| EPS (Diluted) | $-0.80 | $-0.19 | $-0.23 | $-0.28 | $-0.37 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | |
| Shares (Basic) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 | |
| Shares (Diluted) | 93,510,544 | 53,381,989 | · | 51,017,662 | 34,685,072 | 34,685,072 | · | 34,355,050 | 34,318,709 | 25,048,134 | 21,127,281 | 19,048,627 | 17,917,769 | 9,693,788 | 9,647,726 | 9,458,745 |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $28M | $21M | $32M | $52M | $13M | $13M | $10M | $15M | $66M | $20M | $25M | $17M | $18M | $29M | $36M | |
| Short-term Investments | $139M | $1M | $15M | $16M | $4M | $10M | $22M | $33M | $47M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | · | · | $2M | $2M | $2M | · | $3M | $1M | $1M | $2M | $958.0K | $2M | $3M | $1M | $1M | |
| Current Assets | $188M | $31M | $40M | $50M | $57M | $25M | $36M | $46M | $63M | $68M | $22M | $26M | $18M | $21M | $31M | $38M | |
| PP&E (Net) | · | · | $3.0K | · | · | · | $8.0K | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $256.0K | · | · | · | $256.0K | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $253.0K | · | · | · | $248.0K | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Intangibles | $640.0K | $696.0K | $751.0K | $807.0K | $863.0K | $918.0K | $974.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Total Assets | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Accounts Payable | · | · | · | $2M | $1M | $2M | · | $1M | $550.0K | $373.0K | $638.0K | $361.0K | $1M | $412.0K | $656.0K | $418.0K | |
| Accrued Liabilities | $200.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $198M | $12M | $9M | $10M | $9M | $7M | $7M | $7M | $14M | $21M | $4M | $3M | $20M | $7M | $5M | $4M | |
| Capital Leases | · | · | $5.0K | $21.0K | $37.0K | $52.0K | $66.0K | · | · | · | $22.0K | $38.0K | $54.0K | · | · | · | |
| Total Liabilities | $205M | $22M | $20M | $18M | $17M | $17M | $18M | $17M | $23M | $21M | $20M | $19M | $20M | $23M | $21M | $19M | |
| Common Stock | $170.0K | $121.0K | $121.0K | $121.0K | $118.0K | $103.0K | $103.0K | $103.0K | $103.0K | $103.0K | $90.0K | $90.0K | $87.0K | $79.0K | $79.0K | $79.0K | |
| Retained Earnings | $-345M | $-270M | $-260M | $-246M | $-231M | $-218M | $-206M | $-193M | $-181M | $-172M | $-160M | $-153M | $-145M | $-125M | $-112M | $-101M | |
| AOCI | $-88.0K | $2.0K | $10.0K | $9.0K | $3.0K | $6.0K | $31.0K | $75.0K | $-7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Stockholders' Equity | $-15M | $11M | $22M | $34M | $42M | $10M | $21M | $31M | $42M | $49M | $4M | $10M | $443.0K | $1M | $13M | $21M | |
| Liabilities + Equity | $190M | $33M | $42M | $52M | $59M | $27M | $39M | $48M | $65M | $70M | $24M | $29M | $21M | $24M | $34M | $41M | |
| Shares Outstanding | 102,717,200 | 53,240,988 | 53,233,988 | 52,812,488 | 49,685,072 | 34,685,072 | 34,685,072 | 34,389,946 | 34,341,303 | 34,251,911 | 21,165,760 | 21,105,760 | 17,930,362 | 9,710,747 | 9,681,855 | 9,473,577 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $58.0K | $57.0K | $57.0K | $54.0K | $55.0K | $62.0K | $58.0K | $57.0K | $57.0K | $57.0K | $58.0K | $55.0K | $58.0K | $55.0K | $56.0K | $60.0K | |
| Stock-based Comp | $7M | $-685.0K | $1M | $2M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $829.0K | $840.0K | $823.0K | |
| Amort. of Intangibles | · | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | |
| Operating Cash Flow | $-11M | $-7M | $-18M | $-11M | $-9M | $-11M | $-9M | $-10M | $-5M | $-5M | $-5M | $-7M | $-8M | $-11M | $-8M | $-7M | |
| Investing Cash Flow | $-138M | $14M | $709.0K | $-13M | $7M | $11M | $12M | $13M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $168M | $21.0K | $6M | $4M | · | · | $682.0K | $-8M | $-153.0K | $56M | $0 | $15M | $47.0K | $146.0K | $1M | $95.0K | |
| Net Change in Cash | $20M | $7M | $-11M | $-20M | $39M | $263.0K | $3M | $-5M | $-52M | $51M | $-5M | $9M | $-8M | $-11M | $-7M | $-7M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -60.0% | -33.6% | · | -28.9% | -20.6% | -26.3% | · | -34.6% | -18.1% | -14.3% | -29.6% | -26.2% | -29.3% | -42.5% | -26.3% | -20.4% | |
| ROE | -554.0% | -97.0% | · | -44.4% | -30.3% | -43.0% | · | -70.7% | -32.6% | -26.0% | -279.7% | -72.1% | -82.2% | -73.2% | -38.8% | -29.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 2.6 | · | 5.1 | 6.6 | 3.5 | · | 6.8 | 4.6 | 3.3 | 5.4 | 7.7 | 0.9 | 3.0 | 5.8 | 9.4 | |
| Quick Ratio | 0.9 | 2.5 | · | 4.9 | 6.5 | 3.3 | · | 6.4 | 4.5 | 3.2 | 4.9 | 7.3 | 0.8 | 2.6 | 5.5 | 9.1 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.14 | $0.20 | · | $0.64 | $0.84 | $0.30 | · | $0.91 | $1.23 | $1.44 | $0.19 | $0.46 | $0.02 | $0.11 | $1.36 | $2.26 | |
| Cash Flow / Share | · | $-0.13 | · | · | · | $-0.32 | · | · | · | $-0.21 | · | · | $-0.46 | · | · | · | |
| Cash / Share | $0.47 | $0.53 | · | $0.60 | $1.04 | $0.38 | · | $0.28 | $0.43 | $1.94 | $0.94 | $1.19 | $0.92 | $1.87 | $3.03 | $3.84 | |
| EPS (TTM) | $-1.50 | $-1.07 | · | $-1.39 | $-1.47 | $-1.35 | · | $-1.10 | $-1.08 | $-1.26 | $-2.04 | $-3.05 | $-3.70 | $-3.92 | $-3.28 | $-3.73 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-114M | $-52M | · | $-52M | $-50M | $-46M | · | $-33M | $-28M | $-27M | $-36M | $-42M | $-44M | $-38M | $-32M | $-33M | |
| Market Cap | $671M | $157M | · | $166M | $112M | $93M | · | $163M | $161M | $156M | $91M | $110M | $122M | $32M | $47M | $72M | |
| P/E | -4.4 | -2.7 | · | -2.3 | -1.5 | -2.0 | · | -4.3 | -4.4 | -3.6 | -2.1 | -1.7 | -1.8 | -0.8 | -1.5 | -2.0 | |
| P/B | -45.7 | 14.7 | · | 4.9 | 2.7 | 9.0 | · | 5.2 | 3.8 | 3.2 | 22.5 | 11.3 | 275.2 | 30.7 | 3.6 | 3.3 | |
| P / Tangible Book | · | 17.5 | · | 5.2 | 2.8 | 11.1 | · | 5.6 | 4.0 | 3.3 | 51.9 | 14.9 | · | · | 4.5 | 3.8 | |
| P / Cash Flow | · | -22.6 | · | · | · | -8.4 | · | · | · | -29.5 | · | · | -14.7 | · | · | -10.6 | |
| Earnings Yield | -23.0% | -36.4% | · | -44.1% | -65.0% | -50.6% | · | -23.2% | -23.0% | -27.7% | -47.4% | -58.8% | -54.4% | -118.8% | -67.2% | -49.3% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-55M | $-40M | $-30M | $-42M | $-33M |
| EPS Dilusian | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | · | 5.5 | 0.8 | · | 9.8 |
| Rasio Cepat | · | 5.1 | 0.7 | · | 9.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | · | · | $-24M | · | · |
Pemilik institusional (13F) 123 pengaju · $548.5M total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
123
Nilai yang dipegang
$548.5M
Posisi baru
48
Posisi yang keluar
17
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 48 (+29 vs Kuartal sebelumnya) | 17 (+8 vs Kuartal sebelumnya) | 40 (+20 vs Kuartal sebelumnya) | 14 (-9 vs Kuartal sebelumnya) | +59.9M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $49.724.879 | 7.614.836 | 9,06% | Saham |
| TPG GP A, LLC | $44.910.597 | 6.877.580 | 8,19% | Saham |
| venBio Partners LLC | $38.623.122 | 5.914.720 | 7,04% | Saham |
| Logos Global Management LP | $35.425.250 | 5.425.000 | 6,46% | Saham |
| BlackRock, Inc. | $34.426.271 | 5.272.017 | 6,28% | Saham |
| FRANKLIN RESOURCES INC | $32.344.527 | 4.953.220 | 5,90% | Saham |
| Paradigm Biocapital Advisors LP | $32.335.620 | 4.951.856 | 5,89% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.039.502 | 4.140.812 | 4,93% | Saham |
| Propel Bio Management, LLC | $26.342.138 | 4.034.018 | 4,80% | Saham |
| MARSHALL WACE, LLP | $24.620.145 | 3.770.313 | 4,49% | Saham |
| STATE STREET CORP | $19.234.285 | 2.945.526 | 3,51% | Saham |
| Venrock Adviser, LLC | $17.964.239 | 2.751.032 | 3,27% | Saham |
| Vivo Capital, LLC | $17.964.239 | 2.751.032 | 3,27% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $14.496.600 | 2.220.000 | 2,64% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $13.471.818 | 2.062.721 | 2,46% | Saham |
| Alyeska Investment Group, L.P. | $12.574.965 | 1.925.722 | 2,29% | Saham |
| VANGUARD GROUP INC | $12.297.331 | 2.474.312 | 2,24% | Saham |
| Simplify Asset Management Inc. | $9.351.646 | 1.432.105 | 1,70% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $9.317.755 | 1.426.915 | 1,70% | Saham |
| Caption Management, LLC | $7.676.015 | 1.175.500 | 1,40% | Opsi beli |
| LPL Financial LLC | $5.891.725 | 902.255 | 1,07% | Saham |
| NORTHERN TRUST CORP | $4.856.753 | 743.760 | 0,89% | Saham |
| Spruce Street Capital LP | $4.810.240 | 736.637 | 0,88% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $3.877.194 | 593.751 | 0,71% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.771.075 | 577.500 | 0,69% | Opsi beli |
| RAYMOND JAMES FINANCIAL INC | $3.567.457 | 546.318 | 0,65% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3.510.502 | 537.596 | 0,64% | Saham |
| KVP Capital Advisors, LP | $3.019.178 | 462.355 | 0,55% | Saham |
| TWO SIGMA INVESTMENTS, LP | $2.880.951 | 441.187 | 0,53% | Saham |
| UBS Group AG | $2.043.916 | 313.004 | 0,37% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.515.861 | 232.138 | 0,28% | Saham |
| Caption Management, LLC | $1.487.096 | 227.733 | 0,27% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1.483.472 | 227.178 | 0,27% | Saham |
| Bank of New York Mellon Corp | $1.424.364 | 218.126 | 0,26% | Saham |
| JANE STREET GROUP, LLC | $1.331.467 | 203.900 | 0,24% | Opsi beli |
| CITADEL ADVISORS LLC | $1.326.243 | 203.100 | 0,24% | Opsi beli |
| Nuveen, LLC | $1.248.210 | 191.150 | 0,23% | Saham |
| BANK OF AMERICA CORP /DE/ | $1.208.540 | 185.075 | 0,22% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $1.162.660 | 178.049 | 0,21% | Saham |
| WELLS FARGO & COMPANY/MN | $1.114.233 | 170.633 | 0,20% | Saham |
| TWO SIGMA ADVISERS, LP | $1.043.203 | 209.900 | 0,19% | Saham |
| CITADEL ADVISORS LLC | $804.032 | 123.129 | 0,15% | Saham |
| CANTOR FITZGERALD, L. P. | $794.250 | 121.631 | 0,14% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $791.534 | 121.215 | 0,14% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $677.161 | 103.700 | 0,12% | Opsi jual |
| Shay Capital LLC | $606.049 | 92.810 | 0,11% | Saham |
| XTX Topco Ltd | $587.896 | 90.030 | 0,11% | Saham |
| RHUMBLINE ADVISERS | $568.253 | 87.023 | 0,10% | Saham |
| Blue Trust, Inc. | $560.849 | 85.888 | 0,10% | Saham |
| Diametric Capital, LP | $530.098 | 81.179 | 0,10% | Saham |
Aktivis & pemilik 5%+ 9 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P., venBio Global Strategic GP V, LLC | 27 April 2026 | 9,99% | Pengajuan awal | Investasi pasif | SEC |
| TPG GP A, LLC, James G. Coulter, Jon Winkelried | 24 April 2026 | 12,60% | Pengajuan awal | Kampanye dewan | SEC |
| Dialectic Capital Management, LP, Dialectic Partners, LLC, Dialectic Life Sciences SPV LLC, Dialectic LS Manager LLC, John Fichthorn ×3 pengajuan | 23 Maret 2023 | · | Pengajuan awal | · | SEC |
| Anthony Clarke | 11 Agu 2017 | · | Pengajuan awal | Investasi pasif | SEC |
| Richard Stewart | 11 Agu 2017 | · | Pengajuan awal | Investasi pasif | SEC |
| Working Opportunity Fund (EVCC) Ltd., GrowthWorks Capital Ltd. ×5 pengajuan | 14 Feb. 2011 | · | Pengajuan awal | · | SEC |
| 28 Okt. 2010 | · | Pengajuan awal | · | SEC | |
| Abingworth LLP | 20 Agu 2010 | · | Pengajuan awal | Investasi pasif | SEC |
| SCHERING BERLIN VENTURE CORPORATION, SCHERING BERLIN INC., SCHERING INTERNATIONAL HOLDING GmbH, SCHERING AKTIENGESELLSCHAFT | 31 Okt. 2005 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 48 orang dalam · 17 pejabat · 26 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Andrew D. Goldberg | CEO and President | 18 April 2026 A | · | 0 | 0 | $0 |
| John Bencich | CEO | 16 Agu 2024 A | 100.636 | 0 | 0 | $0 |
| Mark K Oki | Chief Financial Officer | 28 Jan. 2026 A | 127.940 | 0 | 0 | $0 |
| Michelle Renee Griffin | CFO | 8 Mei 2012 A | · | 0 | 0 | $0 |
| Stephen Charles Anderson | CFO and Secretary | 31 Des. 2009 A | 10.000 | 0 | 0 | $0 |
| Alan Fuhrman | Senior Vice President & CFO | 18 Maret 2008 A | · | 0 | 0 | $0 |
| Cindy Jacobs | President & CMO | 4 Sep. 2025 M | 115.585 | 0 | 0 | $0 |
| Mark Lawrence Rubinstein | Chief Medical Officer | 28 Jan. 2026 A | · | 0 | 0 | $0 |
| Craig Donnelly | Chief Operations Officer | 28 Jan. 2026 A | · | 0 | 0 | $0 |
| Jaime Xinos | Chief Commercial Officer | 28 Jan. 2026 A | 74.432 | 0 | 0 | $0 |
| Jerry Wann | Principal Accounting Officer | 28 Jan. 2026 A | 32.694 | 0 | 0 | $0 |
| Erik Atkisson | Chief Legal Officer | 4 Des. 2025 A | · | 0 | 0 | $0 |
| Anthony Clarke | CSO | 28 April 2022 M | 3.502 | 0 | 0 | $0 |
| Susan D. Wyrick | PAO | 14 Maret 2014 A | 1.312 | 0 | 0 | $0 |
| Cameron William Lawrence | Principal Accounting Officer | 8 Mei 2012 A | 950 | 0 | 0 | $0 |
| Craig Steven Eudy | Principal Accounting Officer | 29 Des. 2006 A | · | 0 | 0 | $0 |
| Michael B Stewart | Sr. VP & Chief Medical Officer | 16 Des. 2005 A | · | 0 | 0 | $0 |
| Richard Alistair Stewart | Direktur | 19 Agu 2026 S | 208.249 | 0 | 1 | $-175.115 |
| Reid Alexander Waldman | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Christopher Nathan Martin | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Thomas Sellig | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Nancy R. Phelan | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Aaron Royston | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Jeffrey S Farrow | Direktur | 27 Juli 2026 A | · | 0 | 0 | $0 |
| Thomas Braxton King | Direktur | 4 Sep. 2025 M | 315.142 | 0 | 0 | $0 |
| Kristen B. Slaoui | Direktur | 6 Juni 2025 A | · | 0 | 0 | $0 |
| Stuart Duty | Direktur | 6 Juni 2025 A | · | 0 | 0 | $0 |
| Bridget A Martell | Direktur | 6 Juni 2025 A | · | 0 | 0 | $0 |
| Vaughn B Himes | Direktur | 22 Jan. 2024 A | · | 0 | 0 | $0 |
| Donald Joseph | Direktur | 31 Mei 2022 A | · | 0 | 0 | $0 |
| Martin A Mattingly | Direktur | 31 Mei 2022 A | 10.500 | 0 | 0 | $0 |
| Jay M Moyes | Direktur | 31 Mei 2022 A | · | 0 | 0 | $0 |
| Scott Daniel Cormack | Direktur | 12 Mei 2020 A | 14.810 | 0 | 0 | $0 |
| PARKER H STEWART | Direktur | 12 Mei 2020 A | 12.500 | 0 | 0 | $0 |
| Neil James Clendeninn | Direktur | 26 Mei 2016 A | 22.421 | 0 | 0 | $0 |
| Jack Goldstein | Direktur | 26 Mei 2016 A | 17.500 | 0 | 0 | $0 |
| David V Smith | Direktur | 26 Mei 2016 A | 9.500 | 0 | 0 | $0 |
| Dwight Winstead | Direktur | 17 Mei 2010 M | 0 | 0 | 0 | $0 |
| Patrick Robert Brady | Direktur | 22 Des. 2009 M | 21.130 | 0 | 0 | $0 |
| Robert E Ivy | Direktur | 18 Mei 2007 M | 1.700 | 0 | 0 | $0 |
| George W Dunbar JR | Direktur | 10 Mei 2007 A | 3.250 | 0 | 0 | $0 |
| VENTURES WEST CAPITAL LTD | Pemilik 10% | 15 Des. 2008 S | 41.763 | 0 | 0 | $0 |
| SAC CAPITAL ADVISORS LLC | Pemilik 10% | 19 Feb. 2004 P | 1.419.752 | 0 | 0 | $0 |
| SAC CAPITAL ASSOCIATES LLC | Pemilik 10% | 19 Feb. 2004 P | 867.376 | 0 | 0 | $0 |
| S A C CAPITAL MANAGEMENT L L C | Pemilik 10% | 19 Feb. 2004 P | 1.419.752 | 0 | 0 | $0 |
| Steven A. Cohen | Pemilik 10% | 19 Feb. 2004 P | 1.419.752 | 0 | 0 | $0 |
| Michael A Martino | · | 6 Juli 2010 M | 11.000 | 0 | 0 | $0 |
| Richard J Klein | · | 29 Des. 2003 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 13 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,78% | 56.308 NS | 31 Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 196.745 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,13% | 264.043 SH | 11 Sep. 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,06% | 45.865 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 731.016 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 83.121 SH | 19 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 447.963 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 1.986.639 SH | 11 Sep. 2026 | Harian |
| PWS · Pacer Funds Trust | 0,02% | 627 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 957.103 SH | 19 Agu 2026 | Harian |
| IWV · iShares Trust | 0,00% | 31.805 SH | 9 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.108.369 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.512 SH | 19 Agu 2026 | Harian |
ACHV Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$13.00
+79,6%
3 17,6%
Beli Kuat
13 76,5%
Beli
1 5,9%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
13 analis · 2026-10-04Target rata-rata $14.15 +95,5%
← Di bawah semua target
Harga saat ini $7.24
Rendah$9.00
Rata-rata$14.15
Tinggi$21.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ACHV | · | -4.0 | · | · | · | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
| SLDB | $445M | -2.8 | · | · | -79.5% | · |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026